Showing results (61-70 of 92) with videos related to
Sort By:
Pageof 10
Cancer Genetics and Cytogenetics|March 25, 2000
Cytogenetic heterogeneity and clonal evolution in synchronous bilateral breast carcinomas and their lymph node metastases from a male patient without any detectable BRCA2 germline mutationA Adeyinka, F Mertens, L Bondeson, et al.Cancer|March 1, 1991
Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortionsH Olsson, J Ranstam, B Baldetorp, et al.Cytometry|January 1, 1992
One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?M Fernö, B Baldetorp, S B Ewers, et al.Cancer Genetics and Cytogenetics|September 1, 1990
Complex karyotypic changes, including rearrangements of 12q13 and 14q24, in two leiomyosarcomasM Nilbert, N Mandahl, S Heim, et al.Human Pathology|March 29, 2001
Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancerP Rudolph, P Alm, H Olsson, et al.Genes, Chromosomes & Cancer|November 1, 1989
Complex karyotypic anomalies in a bizarre leiomyoma of the uterusM Nilbert, S Heim, N Mandahl, et al.British Journal of Cancer|November 1, 1990
Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levelsH Sigurdsson, B Baldetorp, A Borg, et al.Breast Cancer Research and Treatment|April 7, 2000
Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels. South Sweden Breast Cancer Group, and South-East Sweden Breast Cancer GroupM Fernö, O Stål, B Baldetorp, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1995
The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinomaT E Gudmundsson, T Högberg, P Alm, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Methodological aspects of flow cytometry DNA analysis in endometrial carcinoma, with special reference to sampling and reproducibilityT E Gudmundsson, E Långström, P Alm, et al.Pageof 10